5-{[1-(5-chloro-3-fluoro-2-methoxyphenyl)-2-(chloromethyl)-3,3,3-trifluoro-2-hydroxypropyl]amino}-7-fluoro-1H-quinolin-2-one | 1152781-41-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 5-{[1-(5-chloro-3-fluoro-2-methoxyphenyl)-2-(chloromethyl)-3,3,3-trifluoro-2-hydroxypropyl]amino}-7-fluoro-1H-quinolin-2-one
• 英文别名: 5-[[1-(5-chloro-3-fluoro-2-methoxyphenyl)-2-(chloromethyl)-3,3,3-trifluoro-2-hydroxypropyl]amino]-7-fluoro-1H-quinolin-2-one
• CAS: 1152781-41-3
• 化学式: C₂₀H₁₅Cl₂F₅N₂O₃
• 分子量: 497.249
• InChiKey: NHMRNPJINQHXID-UHFFFAOYSA-N

物化性质

• 沸点：
  627.4±55.0 °C(predicted)
• 密度：
  1.543±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  32
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  70.6
• 氢给体数：
  3
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  1,1,1-三氟-2,3-环氧丙烷 、 1-{t-butyldimethylsilyl}-5-{[1-(5-chloro-3-fluoro-2-methoxyphenyl)methylidene]amino}-7-fluoroquinolin-2-one 在 正丁基锂 、 水 、 氯化铵 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 4.16h， 生成 5-[[(5-chloro-3-fluoro-2-methoxyphenyl)(2-trifluoromethyl-oxiranyl)methyl]amino]-7-fluoro-1H-quinolin-2-one 、 5-{[1-(5-chloro-3-fluoro-2-methoxyphenyl)-2-(chloromethyl)-3,3,3-trifluoro-2-hydroxypropyl]amino}-7-fluoro-1H-quinolin-2-one
  参考文献：
  名称：

  5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, A Process for Their Production and Their Use as Anti-inflammatory Agents

  摘要：

  本发明涉及公式I的化合物，其生产过程以及作为抗炎药物的用途。

  公开号：

  US20090137564A1

文献信息

• [EN] PROCESS FOR THE PREPARATION OF SUBSTITUTED 5-{[2-(ALKOXYMETHYL)-3,3,3-TRIFLUORO-2-HYDROXY-1-PHENYLPROPYL]AMINO}QUINOLIN-2(1H)-ONES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE 5- {[2- (ALCOXYMÉTHYL) -3,3,3-TRIFLUORO-2-HYDROXY-1-PHÉNYLPROPYL] AMINO} QUINOLIN -2 (1H)-ONES SUBSTITUÉES
  申请人：BAYER PHARMA AG

  公开号：WO2018046684A1

  公开（公告）日：2018-03-15

  Described is a process as well as intermediates for the preparation of compound of the general formula (I); especially of formula (la) in which the substituents R1, R2, R3, R4 and R5 have the meaning indicated in the present specification.

  本文描述了制备通式(I)化合物的过程和中间体，特别是通式(la)中取代基R1、R2、R3、R4和R5的含义如本说明书所示。
• 5-[(3,3,3-TRIFLUORO-2-HYDROXY-1-ARYLPROPYL)AMINO]-1H-QUINOLIN-2-ONES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
  申请人：BERGER Markus

  公开号：US20130005766A1

  公开（公告）日：2013-01-03

  The present invention relates to compounds of formula I, processes for their production and their use as anti-inflammatory agents.

  本发明涉及式I的化合物，其制备过程以及其作为抗炎剂的用途。
• 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP2062880A1

  公开（公告）日：2009-05-27

  The present invention relates to compounds of formula I, processes for their production and their use as anti-inflammatory agents.

  本发明涉及式 I 的化合物、 的生产工艺及其作为抗炎剂的用途。
• 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, process for their production and their use as anti-inflammatory agents
  申请人：Bayer Intellectual Property GmbH

  公开号：EP2234979B1

  公开（公告）日：2016-05-25
• SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
  申请人：AKRIBES BIOMEDICAL GMBH

  公开号：US20220047602A1

  公开（公告）日：2022-02-17

  The present invention relates to a Selective Glucocorticoid Receptor Modulator (SEGRM), or a pharmaceutically acceptable salt thereof, for use in the treatment of impaired skin wound healing in a subject, an in vitro method for identifying a subject suffering from impaired skin wound healing to be responsive to the treatment with a Selective Glucocorticoid Receptor Modulator (SEGRM), or a pharmaceutically acceptable salt thereof, and kits and kits-of-part related thereto.